Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.

Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med (2013) 1.79

Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet (2013) 1.76

Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD. PLoS Genet (2015) 1.52

Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis. PLoS One (2014) 1.51

Accounting for population stratification in DNA methylation studies. Genet Epidemiol (2014) 1.25

Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med (2013) 1.23

Detection and quantification of methylation in DNA using solid-state nanopores. Sci Rep (2013) 1.19

A functional methylome map of ulcerative colitis. Genome Res (2012) 1.15

DNA methylation data analysis and its application to cancer research. Epigenomics (2013) 1.14

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. Cancer Cell (2014) 1.10

Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma. Oncotarget (2014) 1.03

The chromatin remodeller CHD8 is required for E2F-dependent transcription activation of S-phase genes. Nucleic Acids Res (2013) 1.01

DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma. PLoS One (2013) 1.00

Ion channels expression and function are strongly modified in solid tumors and vascular malformations. J Transl Med (2016) 0.96

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. Oncogene (2013) 0.95

Epigenetics in non-small cell lung cancer: from basics to therapeutics. Transl Lung Cancer Res (2016) 0.94

Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease. Int J Cancer (2014) 0.93

LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT. J Thorac Oncol (2014) 0.92

The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p. Nat Commun (2015) 0.90

In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery. Mol Cell Proteomics (2015) 0.88

Hypermethylation in the ZBTB20 gene is associated with major depressive disorder. Genome Biol (2014) 0.88

SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes. Nat Commun (2015) 0.87

MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc Natl Acad Sci U S A (2015) 0.87

Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer. Epigenetics (2014) 0.86

Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma. Oncotarget (2014) 0.85

Epigenetic therapy in lung cancer. Front Oncol (2013) 0.85

A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets. Cancer Res (2014) 0.84

DNA methylation, early life environment, and health outcomes. Pediatr Res (2015) 0.84

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A (2016) 0.83

Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology. BMC Cancer (2014) 0.83

Heterogeneous DNA methylation contributes to tumorigenesis through inducing the loss of coexpression connectivity in colorectal cancer. Genes Chromosomes Cancer (2014) 0.83

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. Clin Epigenetics (2016) 0.83

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. Oncogene (2015) 0.82

SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer. Sci Rep (2015) 0.82

Methods to increase reproducibility in differential gene expression via meta-analysis. Nucleic Acids Res (2016) 0.82

SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling. Cell Res (2017) 0.81

Immortality, but not oncogenic transformation, of primary human cells leads to epigenetic reprogramming of DNA methylation and gene expression. Nucleic Acids Res (2013) 0.81

Single-cell multimodal profiling reveals cellular epigenetic heterogeneity. Nat Methods (2016) 0.81

DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer. J Exp Clin Cancer Res (2015) 0.81

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer. Sci Rep (2016) 0.81

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer. Cancer Res (2016) 0.80

An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer. Clin Cancer Res (2016) 0.80

Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status. PLoS One (2013) 0.79

DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers. Oncotarget (2015) 0.79

The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution. Elife (2015) 0.79

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer. Oncotarget (2015) 0.78

Tobacco smoking and methylation of genes related to lung cancer development. Oncotarget (2016) 0.78

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers. J Thorac Oncol (2015) 0.77

The expression profile and clinic significance of the SIX family in non-small cell lung cancer. J Hematol Oncol (2016) 0.77

MODMatcher: multi-omics data matcher for integrative genomic analysis. PLoS Comput Biol (2014) 0.77

A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modules. Mol Biosyst (2015) 0.77

An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer. Mol Cell Biol (2014) 0.77

Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Mol Carcinog (2015) 0.77

Combined analysis of DNA methylome and transcriptome reveal novel candidate genes with susceptibility to bovine Staphylococcus aureus subclinical mastitis. Sci Rep (2016) 0.76

Hidden among the crowd: differential DNA methylation-expression correlations in cancer occur at important oncogenic pathways. Front Genet (2015) 0.76

TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus. Clin Epigenetics (2016) 0.76

DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers. Cancer Genet (2014) 0.76

Lung cancer transcriptomes refined with laser capture microdissection. Am J Pathol (2014) 0.76

Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer. Cell Death Dis (2016) 0.76

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome. Oncotarget (2016) 0.76

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis. Cell Discov (2016) 0.75

Down-regulation of LAPTM5 in human cancer cells. Oncotarget (2016) 0.75

Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration. PLoS One (2017) 0.75

DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer. Clin Transl Gastroenterol (2016) 0.75

Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma. Sci Rep (2016) 0.75

Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma. Oncotarget (2017) 0.75

Propensity score method for partially matched omics studies. Cancer Inform (2014) 0.75

Multiple functional SNPs in differentially expressed genes modify risk and survival of non-small cell lung cancer in Chinese female non-smokers. Oncotarget (2017) 0.75

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor. Oncotarget (2016) 0.75

The potential role of extracellular regulatory kinase in the survival of patients with early stage adenocarcinoma. J Thorac Dis (2014) 0.75

Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer. Oncotarget (2016) 0.75

TGF-β/ SMAD3 Pathway Stimulates Sphingosine-1-phosphate Receptor 3 Expression: Implication of Sphingosine-1-Phosphate Receptor 3 in Lung Adenocarcinoma Progression. J Biol Chem (2016) 0.75

Feature Selection and Cancer Classification via Sparse Logistic Regression with the Hybrid L1/2 +2 Regularization. PLoS One (2016) 0.75

Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD. Clin Epigenetics (2017) 0.75

Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget (2016) 0.75

Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase. Cancer Gene Ther (2016) 0.75

Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma. Biomed Res Int (2016) 0.75

Genome Wide Methylome Alterations in Lung Cancer. PLoS One (2015) 0.75

Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma. Sci Rep (2017) 0.75

A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data. PLoS One (2016) 0.75

An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter. Cell Rep (2016) 0.75

Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells. Oncogene (2017) 0.75

A potential prognostic biomarker SPC24 promotes tumorigenesis and metastasis in lung cancer. Oncotarget (2017) 0.75

Overexpression and proliferation dependence of acyl-CoA thioesterase 11 and 13 in lung adenocarcinoma. Oncol Lett (2017) 0.75

TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis. Oncol Lett (2017) 0.75

Contextual tumor suppressor function of T cell death-associated gene 8 (TDAG8) in hematological malignancies. J Transl Med (2017) 0.75

TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection. Oncotarget (2017) 0.75

Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis. Oncol Lett (2017) 0.75

Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers. PLoS One (2017) 0.75

Integrated Analysis of DNA Methylation and mRNA Expression Profiles to Identify Key Genes in Severe Oligozoospermia. Front Physiol (2017) 0.75

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64

Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A (2004) 33.85

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med (2005) 25.93

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49

Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med (2002) 21.28

The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet (2009) 18.90

lumi: a pipeline for processing Illumina microarray. Bioinformatics (2008) 17.19

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med (2005) 13.40

CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02

Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet (2010) 11.82

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell (1996) 9.93

Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature (2010) 9.81

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47

CpG island methylator phenotype in cancer. Nat Rev Cancer (2004) 7.13

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77

Lung cancer in never smokers--a different disease. Nat Rev Cancer (2007) 6.41

New driver mutations in non-small-cell lung cancer. Lancet Oncol (2011) 6.03

DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med (2008) 5.87

Cancer epigenetics reaches mainstream oncology. Nat Med (2011) 5.83

Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet (2011) 5.70

Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet (2011) 5.18

Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res (2011) 4.84

ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med (2004) 4.64

Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer (2004) 4.43

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A (2007) 4.16

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res (2011) 4.15

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell (2011) 4.02

CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn (2006) 3.98

Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One (2010) 3.96

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One (2008) 3.87

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell (2009) 3.76

SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet (2001) 3.76

A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res (2009) 3.50

Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer (2001) 3.22

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res (1999) 3.15

Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer (2004) 3.10

Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91

Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol (2006) 2.86

DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One (2011) 2.80

TRAIL and apoptosis induction by TNF-family death receptors. Oncogene (2003) 2.75

Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One (2010) 2.67

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res (2002) 2.56

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res (2003) 2.49

SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood (2002) 2.34

Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res (2008) 2.16

Lung cancer epigenetics and genetics. Int J Cancer (2008) 2.08

Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res (2009) 2.03

Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer (2003) 2.01

Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene (2005) 1.98

DNA methylation and cancer. Oncogene (2002) 1.98

Relevance of DNA methylation in the management of cancer. Lancet Oncol (2003) 1.97

The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell (2011) 1.92

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res (2002) 1.88

Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res (2009) 1.84

DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum Mol Genet (2011) 1.83

Gene expression signature predicts recurrence in lung adenocarcinoma. Clin Cancer Res (2007) 1.80

Wnt signaling in lung cancer. Cancer Lett (2005) 1.77

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene (2011) 1.76

CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett (2008) 1.75

Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers Prev (2010) 1.74

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood (2010) 1.67

Global reactivation of epigenetically silenced genes in prostate cancer. Cancer Prev Res (Phila) (2010) 1.66

Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer (2011) 1.65

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes. Cytoskeleton (Hoboken) (2010) 1.64

Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res (2008) 1.57

Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One (2011) 1.55

Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res (2006) 1.53

Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet (2007) 1.52

Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res (2009) 1.50

MethyLight. Methods Mol Biol (2009) 1.45

ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem (2007) 1.41

Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene (2002) 1.38

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer (2006) 1.35

The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet (1998) 1.35

Wnt and Hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS One (2006) 1.34

Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin Cancer Res (2011) 1.33

The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res (2005) 1.30

Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics (2011) 1.29

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene (2002) 1.28

Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res (2008) 1.27

Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis (2008) 1.27

CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology (2010) 1.26

Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res (2006) 1.23

HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas. Oncogene (2002) 1.23

Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest (2009) 1.22

Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res (2007) 1.19

Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum Mol Genet (2010) 1.19

Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin Cancer Res (2009) 1.19

Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer (2004) 1.19

Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun (2008) 1.19

A novel adhesion molecule in human breast cancer cells: voltage-gated Na+ channel beta1 subunit. Int J Biochem Cell Biol (2008) 1.17

TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival. J Biol Chem (2004) 1.17

The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010) 16.12

A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem (2003) 15.88

Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16

Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63

HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00

High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68

Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33

The somatic genomic landscape of glioblastoma. Cell (2013) 11.73

Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79

Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res (2004) 8.86

A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2006) 8.61

Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75

A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet (2004) 7.68

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med (2007) 7.59

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48

HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe (2007) 7.34

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res (2005) 6.93

Probabilistic Boolean Networks: a rule-based uncertainty model for gene regulatory networks. Bioinformatics (2002) 6.90

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA (2011) 6.81

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69

Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res (2005) 6.49

Lung cancer in never smokers--a different disease. Nat Rev Cancer (2007) 6.41

The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37

Pten regulates neuronal arborization and social interaction in mice. Neuron (2006) 6.11

Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res (2010) 6.03

SCAN: SNP and copy number annotation. Bioinformatics (2009) 5.96

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71

Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res (2004) 5.57

Enhanced nitrogen deposition over China. Nature (2013) 5.49

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res (2007) 5.32

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest (2009) 5.07

The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med (2010) 4.78

Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature (2007) 4.70

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70

Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med (2013) 4.64

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One (2009) 4.62

Sequence and analysis of rice chromosome 4. Nature (2002) 4.39

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A (2007) 4.35

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res (2005) 4.25

Concern Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation (2002) 4.16

Developmental fluoride neurotoxicity: a systematic review and meta-analysis. Environ Health Perspect (2012) 4.15

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science (2011) 4.13

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest (2006) 4.06

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05

Nitrogen deposition and its ecological impact in China: an overview. Environ Pollut (2010) 4.03

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res (2005) 3.98

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer (2006) 3.92

Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell (2011) 3.88

Stargazin modulates AMPA receptor gating and trafficking by distinct domains. Nature (2005) 3.88

Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 3.87

Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86

Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res (2006) 3.83

One-year health care costs associated with delirium in the elderly population. Arch Intern Med (2008) 3.82

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res (2005) 3.79

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell (2006) 3.73

Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol (2008) 3.67

Resolving the resolution of array CGH. Genomics (2007) 3.66

Conformational changes of the flavivirus E glycoprotein. Structure (2004) 3.66

Shell-isolated nanoparticle-enhanced Raman spectroscopy. Nature (2010) 3.64

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res (2004) 3.63

Structures of immature flavivirus particles. EMBO J (2003) 3.62

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res (2009) 3.57

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest (2006) 3.49

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res (2012) 3.48

V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature (2006) 3.45

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res (2006) 3.45

PIK3CA mutations and copy number gains in human lung cancers. Cancer Res (2008) 3.42

Focus on lung cancer. Cancer Cell (2002) 3.41

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res (2006) 3.40

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology (2010) 3.37

Genetic architecture of transcript-level variation in humans. Am J Hum Genet (2008) 3.36

DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One (2007) 3.30

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun (2004) 3.29

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature (2013) 3.27

The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science (2008) 3.26

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res (2004) 3.23

Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst (2003) 3.21

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res (2006) 3.21

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell (2006) 3.20